author-photo

Graham McIlroy

University of Birmingham

22

Papers

129

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Ponatinib in Combination with FLAG-IDA Chemotherapy for Blast-Phase Chronic Myeloid Leukemia: Final Results of the Seamless Phase I/II Dose-Finding UK Trials Acceleration Programme (TAP) Matchpoint Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center.

2020 Cell Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Improved Outcomes With Allogeneic Compared With Autologous Stem Cell Transplantation in Aggressive T-cell Lymphoma

2020 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease

2019 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (3)
Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation

2019 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (1)
EXPLORING THE REAL-LIFE CLINICAL VALUE OF LOW DOSE DIRECT ANTICOAGULANTS FOR SECONDARY PREVENTION OF THROMBOEMBOLISM: PF795

2019
Show All
- Source
- Cite
- Save
Citations (0)
Treatment Failure in Patients Receiving Direct Oral Anticoagulants: Clinical Management and Outcomes from a Single-Center Review of 59 Consecutive Patients

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)